In other words, the price has increased by $0.0000 from its previous closing price. On the day, 1581246 shares were traded. PGEN stock price reached its highest trading level at $1.5260 during the session, while it also had its lowest trading level at $1.4100.
Ratios:
For a better understanding of PGEN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.83 and its Current Ratio is at 2.83. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.
On February 25, 2021, Stifel started tracking the stock assigning a Buy rating and target price of $13.Stifel initiated its Buy rating on February 25, 2021, with a $13 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 28 ’23 when KIRK RANDAL J bought 96,686 shares for $1.41 per share. The transaction valued at 136,327 led to the insider holds 1,096,686 shares of the business.
KINDLER JEFFREY B sold 96,686 shares of PGEN for $136,327 on Dec 28 ’23. The Director now owns 238,275 shares after completing the transaction at $1.41 per share. On Sep 22 ’23, another insider, MITCHELL DEAN J, who serves as the Director of the company, bought 25,000 shares for $1.41 each. As a result, the insider paid 35,250 and bolstered with 356,836 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 355.95M and an Enterprise Value of 289.59M. For the stock, the TTM Price-to-Sale (P/S) ratio is 52.66 while its Price-to-Book (P/B) ratio in mrq is 2.48. Its current Enterprise Value per Revenue stands at 42.84 whereas that against EBITDA is -3.75.
Stock Price History:
Over the past 52 weeks, PGEN has reached a high of $1.88, while it has fallen to a 52-week low of $0.81. The 50-Day Moving Average of the stock is 1.4396, while the 200-Day Moving Average is calculated to be 1.3225.
Shares Statistics:
Over the past 3-months, PGEN traded about 1.18M shares per day on average, while over the past 10 days, PGEN traded about 1.04M shares per day. A total of 208.15M shares are outstanding, with a floating share count of 124.08M. Insiders hold about 49.77% of the company’s shares, while institutions hold 30.46% stake in the company. Shares short for PGEN as of Feb 29, 2024 were 17.27M with a Short Ratio of 14.70, compared to 18.71M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.94% and a Short% of Float of 11.69%.
Earnings Estimates
Current recommendations for the stock of the company come from 4 analysts. On average, analysts expect EPS of -$0.08 for the current quarter, with a high estimate of -$0.07 and a low estimate of -$0.08, while EPS last year was -$0.11. The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.07 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.33 and -$0.41 for the fiscal current year, implying an average EPS of -$0.35. EPS for the following year is -$0.31, with 4 analysts recommending between -$0.25 and -$0.39.
Revenue Estimates
A total of 4 analysts have provided revenue estimates for PGEN’s current fiscal year. The highest revenue estimate was $7.5M, while the lowest revenue estimate was $5M, resulting in an average revenue estimate of $6.7M. In the same quarter a year ago, actual revenue was $26.91M, down -75.10% from the average estimate.
